Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily

Biochemical Journal

Volumn 440, Issue 3, 2011, Pages 335-344

  Ruiz, F Xavier ^a   Porté, Sergio ^a   Gallego, Oriol ^a   Moro, Armando ^a   Ardèvol, Albert ^b   Del Río Espínola, Alberto ^a   Rovira, Carme ^b,c   Farrés, Jaume ^a   Parés, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Aldo keto reductase (AKR); Proliferation; Retinaldehyde; Retinoic acid; Retinol

Indexed keywords

ALDO KETO REDUCTASE; FLUFENAMIC ACID; LITHOCHOLIC ACID; OXIDOREDUCTASE; RETINAL; RETINOIC ACID DERIVATIVE; RETINOL; UNCLASSIFIED DRUG; UV 12024;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONFORMATION; ENZYME ACTIVITY; ENZYME KINETICS; GENE OVEREXPRESSION; HELA CELL; HUMAN; IN VIVO STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

20-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; AMINO ACID SUBSTITUTION; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; HYDROXYSTEROID DEHYDROGENASES; KINETICS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; OXIDOREDUCTASES; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RETINALDEHYDE; SUBSTRATE SPECIFICITY; TRANSCRIPTIONAL ACTIVATION; VITAMIN A;

EID: 82455186762     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111286     Document Type: Article

References (50)

1. Theodosiou, M., Laudet, V. and Schubert, M. (2010) From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell. Mol. Life Sci. 67, 1423-1445
2. Tang, X. H. and Gudas, L. J. (2011) Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 6, 345-364
3. Gallego, O., Belyaeva, O. V., Porté, S., Ruiz, F. X., Stetsenko, A. V., Shabrova, E. V., Kostereva, N. V., Farrés, J., Parés, X. and Kedishvili, N. Y. (2006) Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem. J. 399, 101-109 (Pubitemid 44505411)
4. Parés, X., Farrés, J., Kedishvili, N. and Duester, G. (2008) Medium- and short-chain dehydrogenase/reductase gene and protein families: medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell. Mol. Life Sci. 65, 3936-3949
5. Crosas, B., Cederlund, E., Torres, D., Jörnvall, H., Farrés, J. and Parés, X. (2001) A vertebrate aldo-keto reductase active with retinoids and ethanol. J. Biol. Chem. 276, 19132-19140
6. Crosas, B., Hyndman, D. J., Gallego, O., Martras, S., Parés, X., Flynn, T. G. and Farrés, J. (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem. J. 373, 973-979 (Pubitemid 36981109)
7. Penning, T. M., Jin, Y., Steckelbroeck, S., Lanisnik Rizner, T. and Lewis, M. (2004) Structure-function of human 3α-hydroxysteroid dehydrogenases: genes and proteins. Mol. Cell. Endocrinol. 215, 63-72 (Pubitemid 38337424)
8. Matsuura, K., Deyashiki, Y., Sato, K., Ishida, N., Miwa, G. and Hara, A. (1997) Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. Biochem. J. 323, 61-64
9. Penning, T. M., Burczynski, M. E., Jez, J. M., Hung, C. F., Lin, H. K., Ma, H., Moore, M., Palackal, N. and Ratnam, K. (2000) Human 3α- hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351, 67-77
10. Jin, Y. and Penning, T. M. (2007) Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 47, 263-292
11. Matsunaga, T., Shintani, S. and Hara, A. (2006) Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. 21, 1-18
12. Penning, T. M., Steckelbroeck, S., Bauman, D. R., Miller, M. W., Jin, Y., Peehl, D. M., Fung, K. M. and Lin, H. K. (2006) Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Mol. Cell. Endocrinol. 248, 182-191
13. Penning, T. M. and Drury, J. E. (2007) Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 464, 241-250 (Pubitemid 47214569)
14. Marín, Y. E., Seiberg, M. and Lin, C. B. (2009) Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival. Exp. Dermatol. 18, 611-618
15. Veitch, Z. W., Guo, B., Hembruff, S. L., Bewick, A. J., Heibein, A. D., Eng, J., Cull, S., Maclean, D. A. and Parissenti, A. M. (2009) Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance. Pharmacogenet. Genomics 19, 477-488
16. 2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells. Mol. Cell. Endocrinol. 289, 60-66
17. Byrns, M. C., Duan, L., Lee, S. H., Blair, I. A. and Penning, T. M. (2010) Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. J. Steroid Biochem. Mol. Biol. 118, 177-187
18. Penning, T. M. and Byrns, M. C. (2009) Steroid hormone transforming aldo-keto reductases and cancer. Ann. N.Y. Acad. Sci. 1155, 33-42
19. Hsu, N. Y., Ho, H. C., Chow, K. C., Lin, T. Y., Shih, C. S., Wang, L. S. and Tsai, C. M. (2001) Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res. 61, 2727-2731
20. Khanim, F. L., Hayden, R. E., Birtwistle, J., Lodi, A., Tiziani, S., Davies, N. J., Ride, J. P., Viant, M. R., Gunther, U. L., Mountford, J. C. et al. (2009) Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. PLoS ONE 4, e8147
21. Chien, C. W., Ho, I. C. and Lee, T. C. (2009) Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells. Carcinogenesis 30, 1813-1820
22. Gallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M.,Álvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I. and Parés, X. (2007) Structural basis for the high all-trans- retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U. S.A. 104, 20764-20769
23. Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W. and Kollman, P. A. (1995) A second generation force-field for the stimulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117, 5179-5197
24. Ruiz, F. X., Gallego, O., Ardèvol, A., Moro, A., Domínguez, M., Álvarez, S., Álvarez, R., de Lera, A. R., Rovira, C., Fita, I. et al. (2009) Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels. Chem. Biol. Interact. 178, 171-177
25. Mills, K. I., Gilkes, A. F., Sweeney, M., Choudhry, M. A., Woodgate, L. J., Bunce, C. M., Brown, G. and Burnett, A. K. (1998) Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells. FEBS Lett. 440, 158-162 (Pubitemid 28558756)
26. Desmond, J. C., Mountford, J. C., Drayson, M. T., Walker, E. A., Hewison, M., Ride, J. P., Luong, Q. T., Hayden, R. E., Vanin, E. F. and Bunce, C. M. (2003) The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase- dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res. 63, 505-512 (Pubitemid 36152514)
27. Farr, A. and Roman, A. (1992) A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res. 20, 920
28. Gimeno, A., Zaragoza, R., Viña, J. R. and Miralles, V. J. (2004) Vitamin E activates CRABP-II gene expression in cultured human fibroblasts, role of protein kinase C. FEBS Lett. 569, 240-244 (Pubitemid 38844625)
29. Bauman, D. R., Rudnick, S. I., Szewczuk, L. M., Jin, Y., Gopishetty, S. and Penning, T. M. (2005) Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes. Mol. Pharmacol. 67, 60-68 (Pubitemid 40069966)
30. Nahoum, V., Perez, E., Germain, P., Rodriguez-Barrios, F., Manzo, F., Kammerer, S., Lemaire, G., Hirsch, O., Royer, C. A., Gronemeyer, H. et al. (2007) Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function. Proc. Natl. Acad. Sci. U.S.A. 104, 17323-17328 (Pubitemid 350219841)
31. Byrns, M. C., Steckelbroeck, S. and Penning, T. M. (2008) An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies. Biochem. Pharmacol. 75, 484-493 (Pubitemid 350298472)
32. Jez, J. M., Schlegel, B. P. and Penning, T. M. (1996) Characterization of the substrate binding site in rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: the roles of tryptophans in ligand binding and protein fluorescence. J. Biol. Chem. 271, 30190-30198 (Pubitemid 26389662)
33. Nahoum, V., Gangloff, A., Legrand, P., Zhu, D. W., Cantin, L., Zhorov, B. S., Luu-The, V., Labrie, F., Breton, R. and Lin, S. X. (2001) Structure of the human 3α-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-Å resolution. J. Biol. Chem. 276, 42091-42098
34. Ji, Q., Aoyama, C., Nien, Y. D., Liu, P. I., Chen, P. K., Chang, L., Stanczyk, F. Z. and Stolz, A. (2004) Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 64, 7610-7617 (Pubitemid 39372107)
35. Wiebe, J. P. and Lewis, M. J. (2003) Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 3, 9
36. Steckelbroeck, S., Jin, Y., Gopishetty, S., Oyesanmi, B. and Penning, T. M. (2004) Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 279, 10784-10795 (Pubitemid 38379543)
37. Paik, J., Blaner, W. S. and Swisshelm, K. (2005) Cis-retinol dehydrogenase: 9-cis-retinol metabolism and its effect on proliferation of human MCF7 breast cancer cells. Exp. Cell Res. 303, 183-196 (Pubitemid 39575154)
38. Eppinger, T. M., Buck, J. and Hammerling, U. (1993) Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J. Exp. Med. 178, 1995-2005 (Pubitemid 23344857)
39. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. and Davies, P. J. (1995) Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15, 3540-3551
40. Endo, K., Fukui, M., Mishima, M. and Watanabe, K. (2001) Metabolism of vitamin A affected by prostaglandin F synthase in contractile interstitial cells of bovine lung. Biochem. Biophys. Res. Commun. 287, 956-961 (Pubitemid 32953569)
41. Endo, S., Matsunaga, T., Horie, K., Tajima, K., Bunai, Y., Carbone, V., El-Kabbani, O. and Hara, A. (2007) Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues. Arch. Biochem. Biophys. 465, 136-147 (Pubitemid 47283988)
42. Belyaeva, O. V., Korkina, O. V., Stetsenko, A. V., Kim, T., Nelson, P. S. and Kedishvili, N. Y. (2005) Biochemical properties of purified human retinol dehydrogenase 12 (RDH12): catalytic efficiency toward retinoids and C9 aldehydes and effects of cellular retinol-binding protein type I (CRBPI) and cellular retinaldehyde-binding protein (CRALBP) on the oxidation and reduction of retinoids. Biochemistry 44, 7035-7047 (Pubitemid 40632421)
43. Andreola, F., Giandomenico, V., Spero, R. and De Luca, L. M. (2000) Expression of a smaller lecithin:retinol acyl transferase transcript and reduced retinol esterification in MCF-7 cells. Biochem. Biophys. Res. Commun. 279, 920-924 (Pubitemid 32042877)
44. Rexer, B. N., Zheng, W. L. and Ong, D. E. (2001) Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res. 61, 7065-7070 (Pubitemid 32951773)
45. Duester, G., Mic, F. A. and Molotkov, A. (2003) Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem. Biol. Interact. 143-144, 201-210 (Pubitemid 36246442)
46. Lidén, M. and Eriksson, U. (2006) Understanding retinol metabolism: structure and function of retinol dehydrogenases. J. Biol. Chem. 281, 13001-13004 (Pubitemid 43855207)
47. Blomhoff, R. and Blomhoff, H. K. (2006) Overview of retinoid metabolism and function. J. Neurobiol. 66, 606-630 (Pubitemid 43941649)
48. Kane, M. A., Folias, A. E., Pingitore, A., Perri, M., Obrochta, K. M., Krois, C. R., Cione, E., Ryu, J. Y. and Napoli, J. L. (2010) Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion. Proc. Natl. Acad. Sci. U.S.A. 107, 21884-21889
49. Schuchardt, J. P., Wählstrom, D., Rüegg, J., Giese, N., Stefan, M., Hopf, H., Pongratz, I., Håkansson, H., Eichele, G., Pettersson, K. et al. (2009) The endogenous retinoid metabolite S-4-oxo-9-cis-13,14-dihydro- retinoic acid activates retinoic acid receptor signalling both in vitro and in vivo. FEBS J. 276, 3043-3059
50. 2. Leukemia 23, 292-304